Abstract

Macrophage polarization in response to environmental cues has emerged as an important event in the development of atherosclerosis. Compelling evidences suggest that P21-activated kinases 1 (PAK1) is involved in a wide variety of diseases. However, the potential role and mechanism of PAK1 in regulation of macrophage polarization remains to be elucidated. Here, we observed that PAK1 showed a dramatically increased expression in M1 macrophages but decreased expression in M2 macrophages by using a well-established in vitro model to study heterogeneity of macrophage polarization. Adenovirus-mediated loss-of-function approach demonstrated that PAK1 silencing induced an M2 macrophage phenotype-associated gene profiles but repressed the phenotypic markers related to M1 macrophage polarization. Additionally, dramatically decreased foam cell formation was found in PAK1 silencing-induced M2 macrophage activation which was accompanied with alternation of marker account for cholesterol efflux or influx from macrophage foam cells. Moderate results in lipid metabolism and foam cell formation were found in M1 macrophage activation mediated by AdshPAK1. Importantly, we presented mechanistic evidence that PAK1 knockdown promoted the expression of PPARγ, and the effect of macrophage activation regulated by PAK1 silencing was largely reversed when a PPARγ antagonist was utilized. Collectively, these findings reveal that PAK1 is an independent effector of macrophage polarization at least partially attributed to regulation of PPARγ expression, which suggested PAK1-PPARγ axis as a novel therapeutic strategy in atherosclerosis management.

Highlights

  • Macrophages play crucial roles in regulation of inflammation, innate immunity, and adaptive immunity that the pathophysiology processes induced by macrophage are widely involved in a broad spectrum of acute and chronic inflammatory diseases [1,2,3]

  • We demonstrated that P21-activated kinases 1 (PAK1) silencing shaped macrophage towards to anti-inflammatory M2 macrophage, and it mediated M2 macrophage activation dramatically decreased foam cell formation by released cellular cholesterol constituents characterized as upregulated ATP-binding cassette transporter A1 (ABCA1) and ATP-binding cassette transporter G1 (ABCG1) expression but downregulated CD36 and scavenger receptor type A (SR-A) expression

  • The current study showed a remarkable enhanced M2 polarized macrophage genes but reduced M1 polarized macrophage marker expression in bone marrow-derived macrophages (BMDMs) infected with AdshPAK1

Read more

Summary

Introduction

Macrophages play crucial roles in regulation of inflammation, innate immunity, and adaptive immunity that the pathophysiology processes induced by macrophage are widely involved in a broad spectrum of acute and chronic inflammatory diseases [1,2,3]. Administrated with integration of interferon-γ (IFN-γ) and Toll-like receptor 4 (TLR4) ligand lipopolysaccharide (LPS), macrophages turns to a classical proinflammatory macrophage phenotype (M1) that regulate inflammatory response by degradation of basement membrane by secretion of extracellular matrix metalloproteinases (MMPs), production of cytokines, and chemokines. Macrophages undergo alternative activation (M2) change upon IL-4 and IL-13 stimulation that are associated with resolution of inflammation and tissue repair mediated by secretion of anti-inflammatory cytokines [4,5,6,7]. In the past dozens of years, a spectrum of activation programs and underlying molecular mechanisms in M1 and M2 polarized. The distinct function of M1 and M2 macrophage polarization implicated in atherogenesis prompts us to explore important regulators and underlying molecular mechanisms

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call